TGFB1 and chronic kidney disease: The cytokine TGF-β1 is thought to be the most important mediator driving the progression of interstitial fibrosis in CKD, with upregulation of TGF-β1-driven signalling resulting in a host of pro-fibrotic effects which have led to its description as the “master regulator of fibrosis” [18].